Human medicines European public assessment report (EPAR): Azacitidine Adienne, azacitidine, Status: Application withdrawn

Human medicines European public assessment report (EPAR): Cavoley, pegfilgrastim, Status: Opinion

Human medicines European public assessment report (EPAR): Evlarco, obicetrapib,ezetimibe, Status: Opinion

Human medicines European public assessment report (EPAR): Icotyde, icotrokinra hydrochloride, Status: Opinion

Human medicines European public assessment report (EPAR): KemSu, sufentanil,ketamine, Status: Opinion

Human medicines European public assessment report (EPAR): Lynavoy, Linerixibat, Status: Opinion

Human medicines European public assessment report (EPAR): Lyrokaul, lerodalcibep, Status: Opinion

Human medicines European public assessment report (EPAR): Meplyffa, arimoclomol, Status: Opinion

Human medicines European public assessment report (EPAR): Qezzaqar, catequentinib, Status: Opinion

Human medicines European public assessment report (EPAR): Susvimo, ranibizumab, Status: Opinion